Louise Batty

Ms. Batty has over a decade of transactional and advisory experience, as well as significant experience advising target companies and acquirers regarding the impact of corporate events on remuneration and incentive arrangements, with a detailed understanding of corporate transactions and their relation to incentives. She has acted as strategic adviser to listed companies on governance and regulatory issues, including high-profile senior personnel matters (e.g., executive appointments and departures). She has advised clients across all sectors and at all stages of development, from FTSE- and AIM-listed companies to startups and mid-sized companies.

Ms. Batty advised on the incentives aspects of the following transactions prior to joining Skadden:

Public M&A Transactions

• Virgin Money plc in its £4.4 billion merger with CYBG plc;
• BTG plc in its acquisition by Boston Scientific Corporation by way of general offer;
• Consort Medical plc in the £505 million recommended cash offer by Recipharm AB;
• TT Electronics plc in its recommended cash acquisition of Stadium Group plc;
• ICAMAP Investments S.à r.l. in its consortium bid for Easyhotel plc;
• Pennon Group plc in its £4.2 billion disposal of Viridor to KKR;

Equity Capital Markets Transactions

• Sensyne Health plc in its £225 million AIM IPO;
• DWF Group plc in its listing on the premium segment of the London Stock Exchange;
• Network International Holdings plc in its listing on the premium segment of the London Stock Exchange;
• Marks and Spencer in its £601.3 million rights issue to fund its joint venture with Ocado;
• SIG plc in its £165 million firm placing and placing and open offer;

Private Company/Private Equity Transactions

• Vision RT Limited in its acquisition by William Demant Invest;
• Greensill Capital in its US$800 million investment by Softbank Vision Fund;
• Loxam on its £60 million acquisition of U.K. platforms from HSS Hire Group; and
• Transferwise on its US$3.5 billion secondary share sale.